<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:npr="https://www.npr.org/rss/" xmlns:nprml="https://api.npr.org/nprml" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:media="http://search.yahoo.com/mrss/" version="2.0">
  <channel>
    <title>NPR: chicago medicine</title>
    <link>https://www.npr.org/templates/story/story.php?storyId=1131132458</link>
    <description>chicago medicine</description>
    <language>en</language>
    <copyright>Copyright 2024 NPR - For Personal Use Only</copyright>
    <generator>Story API Shim 1.2.24</generator>
    <lastBuildDate>Wed, 20 May 2026 01:24:13 -0400</lastBuildDate>
    <image>
      <url>https://media.npr.org/images/podcasts/primary/npr_generic_image_300.jpg?s=200</url>
      <title>NPR: chicago medicine</title>
      <link>https://www.npr.org/tags/1131132458/chicago-medicine</link>
    </image>
    <item>
      <title>It cost $38,398 for a single shot of a very old cancer drug</title>
      <description>Lupron, a drug patented half a century ago, treats advanced prostate cancer. It costs a few hundred dollars in the U.K. — so why are U.S. hospitals charging so much more to administer it?</description>
      <pubDate>Wed, 26 Oct 2022 05:00:00 -0400</pubDate>
      <link>https://www.npr.org/sections/health-shots/2022/10/26/1131130875/it-cost-38-398-for-a-single-shot-of-a-very-old-cancer-drug</link>
      <guid>https://www.npr.org/sections/health-shots/2022/10/26/1131130875/it-cost-38-398-for-a-single-shot-of-a-very-old-cancer-drug</guid>
      <content:encoded><![CDATA[<p>Lupron, a drug patented half a century ago, treats advanced prostate cancer. It costs a few hundred dollars in the U.K. — so why are U.S. hospitals charging so much more to administer it?</p><img src='https://media.npr.org/include/images/tracking/npr-rss-pixel.png?story=1131130875' />]]></content:encoded>
      <dc:creator>Arthur Allen</dc:creator>
    </item>
  </channel>
</rss>